Neutral impactCompany

Ind-Swift Laboratories Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·5 Oct 2026, 12:41 pm
IND Swift Laboratories LT

Ind‑Swift Laboratories submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September 2026. This filing is a routine compliance requirement for listed companies that hold securities in demat form.

The certificate, filed under Regulation 74(5), confirms that the company’s securities are held in compliance with SEBI rules and that there are no discrepancies in its depository records. For investors, such filings reassure that the shares are properly accounted for and that the company is meeting its regulatory obligations, helping maintain market confidence.

Investors should watch for subsequent quarterly certificates and any related disclosures, as delays or deviations could indicate issues with shareholding patterns or compliance that may affect the stock.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns IND Swift Laboratories LT (INDSWFTLAB).
  • Category: Company.

Why it matters

A routine update for IND Swift Laboratories LT. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.